Circadian Variation of Plasma Homovanillic Acid Levels Is Attentuated by Fluphenazine in Patients with Schizophrenia

Allen R. Doran, Rodrigo Labarca, Owen M. Wolkowitz, Alec Roy, Patrice Douillet, David Pickar

Research output: Contribution to journalArticlepeer-review

Abstract

Plasma homovanillic acid (HVA) levels were measured hourly for a 24-hour period in 10 patients with schizophrenia during treatment with placebo and fluphenazine. Ten age- and sex-matched normal volunteers were similarly studied. Diet and activity were carefully controlled and monitored in both patients and controls. A circadian rhythm of the plasma HVA level was found in controls with a nadir in the afternoon and peak values in the early morning hours; when the patients were free from drugs, they showed a similar rhythm with lower amplitudes. Fluphenazine treatment significantly reduced the plasma concentrations of HVA and abolished the 24-hour rhythm. These data suggest that a 24-hour rhythm of the plasma HVA level exists in humans and that the amplitude of this rhythm may be less pronounced in patients with schizophrenia. Treatment with neuroleptic drugs reduces both the absolute levels and the normal circadian rhythm of the plasma HVA level.

Original languageEnglish (US)
Pages (from-to)558-563
Number of pages6
JournalArchives of General Psychiatry
Volume47
Issue number6
DOIs
StatePublished - 1990
Externally publishedYes

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Circadian Variation of Plasma Homovanillic Acid Levels Is Attentuated by Fluphenazine in Patients with Schizophrenia'. Together they form a unique fingerprint.

Cite this